CSIMarket
 



<< Back to Financial Strength by Company within Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry Financial Strength Information


Financial Strength Information & Trends  
 


Category:  


 
Biotechnology & Pharmaceuticals Industry 4 Q 3 Q 2 Q 1 Q 4 Q
  2024 2024 2024 2024 2023
Quick Ratio (TTM) 0.77 0.76 0.92 1.08 1.3
Quick Ratio Ranking # 14 # 16 # 10 # 11 # 9
Working Capital Ratio (TTM) 1.79 1.8 1.94 2.11 2.38
Working Capital Ratio Ranking # 22 # 18 # 18 # 15 # 4
Working Capital Per Revenue 0.41 0.4 0.49 0.6 0.7
Working Capital Per Revenue Ranking # 101 # 100 # 101 # 99 # 102
Leverage Ratio (TTM) 2.08 2.2 2.22 2.21 1.94
Leverage Ratio Ranking # 53 # 57 # 55 # 60 # 51
Total Debt to Equity (TTM) 1.3 1.37 1.37 1.36 1.19
Total Debt to Equity Ranking # 79 # 79 # 79 # 82 # 77
Interest Coverage (TTM) 3.35 4.18 3.08 1.99 4.35
Interest Coverage Ranking # 88 # 79 # 82 # 88 # 78
Debt Coverage (TTM) 0.14 0.14 0.11 0.09 0.19
Debt Coverage Ranking # 93 # 95 # 96 # 96 # 81


Quick Ratio Comment
On the trailing twelve months basis Current Liabilities decreased faster than Biotechnology & Pharmaceuticals Industry's Cash & cash equivalent, this led to improvement in Biotechnology & Pharmaceuticals Industry's Quick Ratio to 0.77 in the 4 Q 2024,, Quick Ratio remained below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector 2 other industries have achieved higher Quick Ratio. Quick Ratio total ranking has improved so far to 14, from total ranking in previous quarter at 16.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics as of 4 Q 2024
High Average Low
37.9 2.76 0.76
1. quarter 2016   4. quarter 2021

Quick Ratio Industry Ranking
Within: No.
Sector # 3
Overall # 14


Other Quick Ratios
Compare Industry's quick ratio to Om's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for OM's Competitors Definiton of Quick Ratio


Biotechnology & Pharmaceuticals Industry Working Capital Ratio Statistics as of 4 Q 2024
 



Working Capital Ratio Statistics as of 4 Q 2024
High Average Low
4.83 2.44 1.7
1. quarter 2016   2. quarter 2021



Working Capital Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 4 Q 2024, Working Capital Ratio fell to 1.79 below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector 3 other industries have achieved higher Working Capital Ratio. Working Capital Ratio total ranking has deteriorated relative to the previous quarter from 18 to 22.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 4
Overall # 22

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Om's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Working Capital ratios for OM's Competitors Definiton of Working Capital Ratio

Biotechnology & Pharmaceuticals Industry Working Capital Per Revenue Statistics as of 4 Q 2024
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's Working Capital Per Revenue sequentially grew to 0.41 in the 4 Q 2024, below Industry average.



Within Healthcare sector 5 other industries have achieved lower Working Capital Per Revenue. Working Capital Per Revenue total ranking fell in contrast to the preceding quarter from 100 to 101.




Working Capital Per Revenue Statistics as of 4 Q 2024
High Average Low
0.76 0.53 0.06
3. quarter 2016   1. quarter 2016


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 6
Overall # 101



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Om's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Return On Assets for Biotechnology & Pharmaceuticals Industry Definiton of Working Capital Per Revenue



Biotechnology & Pharmaceuticals Industry Leverage Ratio Statistics as of 4 Q 2024
 


Leverage Ratio Statistics as of 4 Q 2024
High Average Low
3.16 1.6 -0.88
3. quarter 2020   1. quarter 2016



Leverage Ratio Comment
Despite net new borrowings of -1.18% Industry managed to improve Liabilities to Equity ratio in 4 Q 2024 to 2.08, above Biotechnology & Pharmaceuticals Industry average.



Among other Industries in the Healthcare sector 5 other industries have achieved lower Leverage Ratio.



Leverage Ratio total ranking has improved so far to 53, from overall ranking in the previous quarter at 57.



Leverage Ratio Industry Ranking
Within: No.
Sector # 6
Overall # 53

Other Leverage Ratios
Compare Industry's Leverage ratio to Om's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for OM's Competitors What is Leverage Ratio?


Biotechnology & Pharmaceuticals Industry Total Debt to Equity Ratio Statistics as of 4 Q 2024
 
Debt to Equity Ratio Comment
Despite net new borrowing of -1.04% Industry managed to improve Total Debt to Equity in 4 Q 2024 to 1.3, above Industry average.



Within Healthcare sector 5 other industries have achieved lower Debt to Equity Ratio. Total ranking remained the same like in the preceding quarter at no. 79.




Debt to Equity Ratio Statistics as of 4 Q 2024
High Average Low
1.37 0.47 0.03
3. quarter 2024   3. quarter 2021



Debt to Equity Industry Ranking
Within: No.
Sector # 6
Overall # 79

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Om's or S&P Definiton of Debt to Equity Ratio

Biotechnology & Pharmaceuticals Industry Interest Coverage Ratio Statistics as of 4 Q 2024
 


Interest Coverage Ratio Statistics as of 4 Q 2024
High Average Low
24.92 8 -89.62
2. quarter 2016   3. quarter 2016

Interest Coverage Ratio Comment
On the trailing twelve months basis Due to increase in interest expenses in 4 Q 2024, Interest Coverage Ratio fell to 3.35 below Biotechnology & Pharmaceuticals Industry average.



In the Healthcare sector 4 other industries have accomplished higher Interest Coverage Ratio. Interest Coverage overall ranking fell in contrast to the prior period from 79 to 88.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 5
Overall # 88

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Om's or S&P Definiton of Interest Coverage Ratio


Biotechnology & Pharmaceuticals Industry Debt Coverage Statistics as of 4 Q 2024
 
Debt Coverage Ratio Comment
On the trailing twelve months basis Despite sequential decrease in total debt, Debt Coverage Ratio detoriated to 0.14 in the 4 Q 2024, below Biotechnology & Pharmaceuticals Industry average.



Looking into Healthcare sector 4 other industries have achieved higher debt coverage ratio. Debt Coverage Ratio total ranking has improved to 93, from total ranking in previous quarter at 95.




Debt Coverage Statistics as of 4 Q 2024
High Average Low
8.77 1.72 -0.13
3. quarter 2021   4. quarter 2015



Debt Coverage Industry Ranking
Within: No.
Sector # 5
Overall # 93

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also Biotechnology & Pharmaceuticals Industry's Margin Definiton of Debt Coverage Ratio

Date modified: 2025-04-23T04:56:21+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com